Skip to main content
. Author manuscript; available in PMC: 2010 Oct 5.
Published in final edited form as: Menopause. 2009 Mar–Apr;16(2):257–264. doi: 10.1097/gme.0b013e318185e249

Table 3.

Results from multivariate models. Each row represents a separate multivariable model.

Models Baseline hormone Change in hormone from baseline
Risk Ratio (95% CI) P Value Risk Ratio (95% CI) P Value
Model 1: E2 0.85 (0.69 - 1.05) 0.13 0.90 (0.73 - 1.11) 0.32
Model 2: T 2.04 (1.45 - 2.86) <0.001 1.28 (0.81 - 2.02) 0.29
Model 3: SHBG 0.58 (0.48 - 0.70) <0.001 0.80 (0.58 - 1.10) 0.20
Model4: FAI 1.77 (1.50 - 2.09) <0.001 1.22 (0.93 - 1.60) 0.16
Model 5: RAE 1.41 (1.17 - 1.69) 0.001 1.24 (1.01 - 1.52) 0.04

All models were adjusted for ethnicity, age at baseline, residual BMI, ‘phlebotomy in window’, site, physical activity, level of education.

Relative Androgen Excess baseline value is the T/E2 molar ratio at study entry.